Treatment of Acute Lymphoblastic Leukemia in Children

Clinical Trial ID NCT00165178

PubWeight™ 17.92^‹?›

🔗 Visit the ClinicalTrials.gov page for NCT00165178

Top papers

Rank	Title	Journal	Year	PubWeight™‹?›
1	Targeting metabolic transformation for cancer therapy.	Nat Rev Cancer	2010	5.90
2	Improved outcome for children with acute lymphoblastic leukemia: results of Dana-Farber Consortium Protocol 91-01.	Blood	2001	3.93
3	The effect of dexrazoxane on myocardial injury in doxorubicin-treated children with acute lymphoblastic leukemia.	N Engl J Med	2004	3.50
4	High frequency of PTEN, PI3K, and AKT abnormalities in T-cell acute lymphoblastic leukemia.	Blood	2009	3.02
5	Childhood T-cell acute lymphoblastic leukemia: the Dana-Farber Cancer Institute acute lymphoblastic leukemia consortium experience.	J Clin Oncol	2003	2.88
6	TYK2-STAT1-BCL2 pathway dependence in T-cell acute lymphoblastic leukemia.	Cancer Discov	2013	1.81
7	Postinduction dexamethasone and individualized dosing of Escherichia Coli L-asparaginase each improve outcome of children and adolescents with newly diagnosed acute lymphoblastic leukemia: results from a randomized study--Dana-Farber Cancer Institute ALL Consortium Protocol 00-01.	J Clin Oncol	2013	1.75
8	Results of Dana-Farber Cancer Institute Consortium protocols for children with newly diagnosed acute lymphoblastic leukemia (1981-1995).	Leukemia	2000	1.58
9	Inactivation of LEF1 in T-cell acute lymphoblastic leukemia.	Blood	2010	1.40
10	Repression of tumor suppressor miR-451 is essential for NOTCH1-induced oncogenesis in T-ALL.	J Exp Med	2011	1.21
11	Absence of biallelic TCRgamma deletion predicts early treatment failure in pediatric T-cell acute lymphoblastic leukemia.	J Clin Oncol	2010	1.14
12	The low incidence of secondary acute myelogenous leukaemia in children and adolescents treated with dexrazoxane for acute lymphoblastic leukaemia: a report from the Dana-Farber Cancer Institute ALL Consortium.	Eur J Cancer	2011	1.10
13	Sequencing histone-modifying enzymes identifies UTX mutations in acute lymphoblastic leukemia.	Leukemia	2012	1.05